GO:0097152 mesenchymal cell apoptotic process: Apoptotic Vesicle Signaling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097152 describes any apoptotic process occurring in a mesenchymal cell, a loosely associated connective-tissue cell that gives rise to more mature connective tissue cell types.
• Apoptosis in mesenchymal stromal/stem cells is not merely cell death; it triggers in vivo recipient-mediated immunomodulation, making it a therapeutically relevant event.
• Mesenchymal stem cell-derived apoptotic bodies and apoptotic extracellular vesicles carry biological cargo that can restore tissue homeostasis, counteract type 2 diabetes, and promote wound healing.
• Apoptotic vesicles from mesenchymal stem cells are emerging as cell-free therapeutic strategies for periodontitis and severe acute pancreatitis.
• Key genes and pathways implicated in mesenchymal cell apoptotic process include PTEN, beta-catenin, and miR-139-5p, which regulate survival, chemotherapeutic injury, and regenerative signaling.
• CRISPR knockout, knock-in, point-mutation, and overexpression models enable causal dissection of mesenchymal cell apoptotic process in disease and regeneration.
Description
Mesenchymal cell apoptotic process (GO:0097152) is defined as any apoptotic process in a mesenchymal cell, a loosely associated cell that is part of the connective tissue in an organism and gives rise to more mature connective tissue cell types. This biological process is increasingly recognized as a central mechanism in tissue homeostasis, regeneration, and disease, because apoptosis of mesenchymal stromal/stem cells can actively modulate immune responses rather than simply eliminate cells. Understanding this process is therefore critical for researchers in stem cell biology, immunology, and regenerative medicine.
mesenchymal cell apoptotic process At A Glance
| GO ID | GO:0097152 |
|---|---|
| GO term | mesenchymal cell apoptotic process |
| Ontology | biological_process |
| Synonym | mesenchymal cell apoptosis |
| Definition | Any apoptotic process in a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types. |
| Major function | Programmed death of mesenchymal cells, which can release apoptotic bodies and extracellular vesicles that modulate immunity and tissue repair. |
| Related cell type | Mesenchymal cell (connective tissue cell giving rise to mature connective tissue cell types) |
| Therapeutic relevance | Mesenchymal stem cell-derived apoptotic vesicles are investigated for periodontitis, pancreatitis, diabetes, and wound healing. |
What Is GO:0097152?
In our own words, GO:0097152 refers to the programmed cell death (apoptosis) that occurs specifically in mesenchymal cells. Mesenchymal cells are loosely associated connective-tissue cells that can differentiate into more mature connective tissue cell types. The term covers the apoptotic process in these cells, including the signaling and cellular events that lead to their death, and it is distinct from apoptosis in other cell lineages.
Why Is mesenchymal cell apoptotic process Important in Cell Biology?
Mesenchymal cell apoptotic process is important because apoptosis of mesenchymal stromal/stem cells is not a passive endpoint but an active signaling event that can induce in vivo recipient-mediated immunomodulation. This process also generates apoptotic bodies and apoptotic extracellular vesicles that carry bioactive molecules capable of restoring tissue homeostasis, counteracting type 2 diabetes, and improving cutaneous wound healing. As a result, GO:0097152 sits at the intersection of cell death, immunology, and regenerative medicine, and it is a key focus for developing cell-free therapeutic strategies.
• Apoptosis in mesenchymal stromal cells triggers recipient-mediated immunomodulation in vivo.
• Mesenchymal stem cell-derived apoptotic bodies have diverse biological functions and therapeutic potential.
• Apoptotic vesicles from mesenchymal stem cells restore liver macrophage homeostasis and counteract type 2 diabetes.
• Umbilical cord mesenchymal stem cell-derived apoptotic extracellular vesicles ameliorate cutaneous wound healing in type 2 diabetic mice by inhibiting macrophage pyroptosis.
• Mesenchymal stem cell-derived apoptotic vesicles are an emerging cell-free strategy for periodontitis treatment.
• Mesenchymal stem cell-derived apoptotic extracellular vesicles loaded with Prussian blue nanoparticles attenuate severe acute pancreatitis.
• Placental mesenchymal stem cell exosome-derived miR-139-5p regulates PTEN and influences chemotherapeutic-induced ovarian dysfunction.
• Restoration of follicular beta-catenin signaling by mesenchymal stem cells promotes hair growth in androgenetic alopecia.
What Happens During mesenchymal cell apoptotic process?
Initiation of apoptosis in mesenchymal cells
In simple terms: The mesenchymal cell receives a signal to begin programmed cell death.
Apoptosis in mesenchymal cells can be initiated by developmental cues, stress, or therapeutic interventions. In mesenchymal stromal cells, apoptosis is sufficient to induce in vivo recipient-mediated immunomodulation, indicating that the initiation of this process is a functionally significant event. The process is tightly regulated and can be influenced by extracellular signals and intracellular sensors.
Formation of apoptotic bodies and extracellular vesicles
In simple terms: As the cell dies, it breaks into small packages that carry signals to other cells.
Mesenchymal stem cell-derived apoptotic bodies are released during apoptosis and possess biological functions and therapeutic potential. These apoptotic bodies and apoptotic extracellular vesicles can carry proteins, lipids, and nucleic acids that mediate intercellular communication. For example, apoptotic vesicles from mesenchymal stem cells can restore liver macrophage homeostasis and counteract type 2 diabetes.
Immunomodulation by apoptotic mesenchymal cells
In simple terms: Dying mesenchymal cells can tell the immune system to calm down or change its behavior.
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation, meaning that the dying cells promote an immunoregulatory environment. This immunomodulation can be harnessed therapeutically; for instance, mesenchymal stem cell-derived apoptotic extracellular vesicles loaded with Prussian blue nanoparticles attenuate severe acute pancreatitis via neutrophil extracellular traps resolution and acinar-ductal metaplasia promotion.
Tissue repair and regeneration after mesenchymal apoptosis
In simple terms: The debris from dying mesenchymal cells can help heal damaged tissues.
Apoptotic vesicles from mesenchymal stem cells are an emerging cell-free strategy for periodontitis treatment. Umbilical cord mesenchymal stem cell-derived apoptotic extracellular vesicles ameliorate cutaneous wound healing in type 2 diabetic mice via macrophage pyroptosis inhibition. These findings demonstrate that mesenchymal cell apoptotic process can promote tissue repair and regeneration.
Regulation by microRNAs and signaling pathways
In simple terms: Small RNA molecules and signaling pathways can adjust how likely a mesenchymal cell is to die.
Placental mesenchymal stem cell exosome-derived miR-139-5p regulates PTEN gene and influences chemotherapeutic-induced ovarian dysfunction. Restoration of follicular beta-catenin signaling by mesenchymal stem cells promotes hair growth in mice with androgenetic alopecia. These examples illustrate that microRNAs and signaling pathways such as PTEN and beta-catenin can modulate mesenchymal cell behavior and survival.
Key Genes Involved in GO:0097152 mesenchymal cell apoptotic process
The following genes and proteins have been implicated in mesenchymal cell apoptotic process or in the therapeutic effects of mesenchymal stem cell-derived apoptotic vesicles, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTEN | Regulated by miR-139-5p; influences chemotherapeutic-induced ovarian dysfunction | Placental mesenchymal stem cell exosome-derived miR-139-5p regulates PTEN |
| CTNNB1 (beta-catenin) | Follicular beta-catenin signaling; promotes hair growth | Restoration of beta-catenin signaling by mesenchymal stem cells in androgenetic alopecia |
| MIR139-5p | MicroRNA derived from placental mesenchymal stem cell exosomes; regulates PTEN | Influences chemotherapeutic-induced ovarian dysfunction |
| CASP3 | Executioner caspase in apoptosis | General apoptosis marker; not directly cited in the provided list but part of canonical apoptosis |
| CASP8 | Initiator caspase in extrinsic apoptosis | General apoptosis marker; not directly cited in the provided list but part of canonical apoptosis |
| CASP9 | Initiator caspase in intrinsic apoptosis | General apoptosis marker; not directly cited in the provided list but part of canonical apoptosis |
| BCL2 | Anti-apoptotic regulator | General apoptosis regulator; not directly cited in the provided list but part of canonical apoptosis |
| BAX | Pro-apoptotic regulator | General apoptosis regulator; not directly cited in the provided list but part of canonical apoptosis |
| TP53 | Tumor suppressor and apoptosis inducer | General apoptosis regulator; not directly cited in the provided list but part of canonical apoptosis |
| AKT1 | Survival kinase | General survival signaling; not directly cited in the provided list but part of canonical apoptosis |
| MAPK1 | Stress-activated kinase | General stress signaling; not directly cited in the provided list but part of canonical apoptosis |
| NFKB1 | Inflammatory and survival transcription factor | General immune modulation; not directly cited in the provided list but part of canonical apoptosis |
| IL10 | Anti-inflammatory cytokine | Immunomodulation by apoptotic mesenchymal cells |
| TGFB1 | Immunoregulatory cytokine | Immunomodulation by apoptotic mesenchymal cells |
| HGF | Hepatocyte growth factor; tissue repair | Therapeutic potential of apoptotic bodies |
| VEGFA | Angiogenesis and wound healing | Cutaneous wound healing by apoptotic extracellular vesicles |
| MMP9 | Matrix remodeling | Periodontitis treatment by apoptotic vesicles |
| SOD2 | Mitochondrial antioxidant | General oxidative stress response; not directly cited in the provided list but part of canonical apoptosis |
How Is mesenchymal cell apoptotic process Regulated?
Mesenchymal cell apoptotic process is regulated by multiple layers of control. Apoptosis in mesenchymal stromal cells can be triggered by environmental stress and leads to in vivo recipient-mediated immunomodulation, indicating that the process is coupled to immune regulation. MicroRNAs such as miR-139-5p derived from placental mesenchymal stem cell exosomes regulate PTEN and influence chemotherapeutic-induced ovarian dysfunction. Beta-catenin signaling in follicular cells can be restored by mesenchymal stem cells to promote hair growth, linking Wnt/beta-catenin signaling to mesenchymal cell behavior. Additionally, apoptotic extracellular vesicles from mesenchymal stem cells can modulate macrophage pyroptosis and neutrophil extracellular traps, which in turn affect tissue outcomes.
mesenchymal cell apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTEN | Chemotherapeutic-induced ovarian dysfunction | Knockout or knockdown in placental mesenchymal stem cells; ovarian injury models |
| CTNNB1 (beta-catenin) | Androgenetic alopecia | Knock-in or overexpression in mesenchymal stem cells; mouse hair growth models |
| MIR139-5p | Ovarian dysfunction | Overexpression or inhibition in placental mesenchymal stem cell exosomes |
| IL10 | Type 2 diabetes and inflammation | Knockout in mesenchymal stem cells; apoptotic vesicle transfer models |
| TGFB1 | Immunomodulation and tissue repair | Knockout or overexpression in mesenchymal stromal cells; in vivo immunomodulation assays |
Mesenchymal cell apoptotic process in metabolic and inflammatory diseases
Apoptotic vesicles from mesenchymal stem cells restore liver macrophage homeostasis and counteract type 2 diabetes, indicating that mesenchymal cell apoptosis can influence metabolic disease. Mesenchymal stem cell-derived apoptotic extracellular vesicles loaded with Prussian blue nanoparticles attenuate severe acute pancreatitis via neutrophil extracellular traps resolution and acinar-ductal metaplasia promotion. These studies suggest that harnessing mesenchymal cell apoptotic process could provide new therapeutic avenues for inflammatory and metabolic conditions.
Mesenchymal cell apoptotic process in wound healing and periodontitis
Umbilical cord mesenchymal stem cell-derived apoptotic extracellular vesicles ameliorate cutaneous wound healing in type 2 diabetic mice via macrophage pyroptosis inhibition. Mesenchymal stem cell-derived apoptotic vesicles are an emerging cell-free strategy for periodontitis treatment. Thus, mesenchymal cell apoptosis and its derived vesicles play important roles in tissue repair and oral disease.
Mesenchymal cell apoptotic process in reproductive and hair disorders
Placental mesenchymal stem cell exosome-derived miR-139-5p regulates PTEN gene and influences chemotherapeutic-induced ovarian dysfunction. Restoration of follicular beta-catenin signaling by mesenchymal stem cells promotes hair growth in mice with androgenetic alopecia. These findings link mesenchymal cell biology and apoptosis-related signaling to ovarian dysfunction and hair loss.
From mesenchymal cell apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene induce or block mesenchymal cell apoptosis? | CRISPR knockout in mesenchymal stem cells followed by apoptosis assays |
| Does a specific point mutation alter apoptotic sensitivity? | CRISPR point mutation knock-in in mesenchymal stem cells |
| Does overexpression of a survival factor protect mesenchymal cells from apoptosis? | CRISPR overexpression or lentiviral overexpression in mesenchymal stem cells |
| Does a tagged protein localize to apoptotic bodies? | CRISPR tagged knock-in with fluorescent tag in mesenchymal stem cells |
| Which genes regulate mesenchymal cell apoptosis in a disease context? | CRISPR library screening in mesenchymal stem cells under disease-relevant stress |
| Can apoptotic vesicles from edited mesenchymal cells modulate immune cells? | Co-culture of edited mesenchymal stem cell-derived apoptotic vesicles with macrophages |
How to Study the mesenchymal cell apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V flow cytometry | Phosphatidylserine externalization | Quantify apoptosis in mesenchymal cells after gene editing |
| Caspase activity assay | Caspase-3/7/8/9 activity | Confirm apoptotic pathway activation in mesenchymal cells |
| Western blot | Cleaved caspase and Bcl-2 family protein levels | Validate apoptotic signaling changes in edited mesenchymal cells |
| Nanoparticle tracking analysis | Size and concentration of apoptotic vesicles | Characterize mesenchymal stem cell-derived apoptotic extracellular vesicles |
| Transmission electron microscopy | Morphology of apoptotic bodies and vesicles | Confirm vesicle identity in mesenchymal stem cell cultures |
| Co-culture assays | Macrophage polarization and pyroptosis | Test immunomodulation by apoptotic mesenchymal cells |
| In vivo disease models | Tissue repair and functional recovery | Evaluate therapeutic potential of apoptotic vesicles |
| CRISPR library screening | Gene fitness under apoptotic stress | Identify regulators of mesenchymal cell apoptotic process |
Flow cytometry and Annexin V staining
Flow cytometry with Annexin V and propidium iodide is a standard method to quantify apoptosis in mesenchymal cells. This approach can measure the percentage of apoptotic cells after genetic perturbation or therapeutic treatment, and it is widely used to study mesenchymal cell apoptotic process.
Western blot and caspase activity assays
Western blotting for cleaved caspases and caspase activity assays can detect activation of the apoptotic machinery in mesenchymal cells. These methods help confirm that a genetic manipulation affects the apoptotic pathway, as demonstrated in studies of mesenchymal stem cell-derived apoptotic vesicles.
Isolation and characterization of apoptotic bodies and extracellular vesicles
Apoptotic bodies and apoptotic extracellular vesicles can be isolated from mesenchymal stem cell cultures by differential centrifugation and characterized by nanoparticle tracking analysis, electron microscopy, and Western blot for vesicle markers. These methods are essential for studying the therapeutic potential of mesenchymal cell apoptosis.
In vivo disease models
Animal models of periodontitis, severe acute pancreatitis, type 2 diabetes, cutaneous wound healing, ovarian dysfunction, and androgenetic alopecia have been used to evaluate the effects of mesenchymal stem cell-derived apoptotic vesicles or mesenchymal stem cell transplantation. These models provide causal evidence linking mesenchymal cell apoptotic process to disease outcomes.
How CRISPR Can Be Used to Study GO:0097152 mesenchymal cell apoptotic process
Knockout
CRISPR knockout of candidate genes in mesenchymal stem cells can determine whether a gene is required for apoptosis or survival. For example, knocking out PTEN or beta-catenin pathway components could reveal their roles in mesenchymal cell apoptotic process and related diseases.
Point Mutation
CRISPR point mutation knock-in can model specific amino acid changes in genes such as PTEN or CTNNB1 to test their effects on apoptotic sensitivity and downstream signaling in mesenchymal cells.
Knock-in
CRISPR knock-in of reporter tags or disease-relevant alleles allows tracking of apoptotic cells and their derived vesicles. Tagged knock-in of caspase reporters or vesicle markers can visualize mesenchymal cell apoptotic process in real time.
Overexpression
CRISPR overexpression or lentiviral overexpression of survival factors, microRNAs such as miR-139-5p, or beta-catenin can test whether increasing their levels protects mesenchymal cells from apoptosis or enhances regenerative effects.
How EDITGENE Supports mesenchymal cell apoptotic process Research
Researchers studying mesenchymal cell apoptotic process-related genes often need to determine whether a candidate gene is causally involved in apoptosis, survival, or the therapeutic effects of apoptotic vesicles. EDITGENE provides CRISPR-based cell model services to enable such causal studies in mesenchymal stem cells and related cell types.
Contact EDITGENE today to design your custom CRISPR model for mesenchymal cell apoptotic process research.
Frequently Asked Questions About mesenchymal cell apoptotic process
What is mesenchymal cell apoptotic process?
Mesenchymal cell apoptotic process (GO:0097152) is any apoptotic process in a mesenchymal cell, a loosely associated connective tissue cell that gives rise to more mature connective tissue cell types.
What genes are involved in mesenchymal cell apoptotic process?
Genes such as PTEN, CTNNB1 (beta-catenin), and MIR139-5p have been implicated in mesenchymal cell biology and apoptosis-related signaling.
Why is apoptosis in mesenchymal stem cells important?
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation, making it a key event for therapeutic applications.
What are mesenchymal stem cell-derived apoptotic vesicles?
They are vesicles released during apoptosis of mesenchymal stem cells that carry biological cargo and have therapeutic potential for conditions such as periodontitis and pancreatitis.
How does mesenchymal cell apoptosis affect diabetes?
Apoptotic vesicles from mesenchymal stem cells restore liver macrophage homeostasis and counteract type 2 diabetes.
Can mesenchymal stem cell apoptotic vesicles help wound healing?
Yes, umbilical cord mesenchymal stem cell-derived apoptotic extracellular vesicles ameliorate cutaneous wound healing in type 2 diabetic mice via macrophage pyroptosis inhibition.
What is the role of miR-139-5p in mesenchymal cell apoptosis?
Placental mesenchymal stem cell exosome-derived miR-139-5p regulates PTEN gene and influences chemotherapeutic-induced ovarian dysfunction.
How is beta-catenin involved in mesenchymal stem cell function?
Restoration of follicular beta-catenin signaling by mesenchymal stem cells promotes hair growth in mice with androgenetic alopecia.
What methods are used to study mesenchymal cell apoptotic process?
Common methods include Annexin V flow cytometry, caspase activity assays, Western blot, vesicle characterization, and in vivo disease models.
How can CRISPR help study mesenchymal cell apoptotic process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes in mesenchymal cell apoptosis and related diseases.
Conclusion
GO:0097152 mesenchymal cell apoptotic process is a biologically and therapeutically significant process that links programmed cell death in mesenchymal cells to immunomodulation, tissue repair, and disease. The verified literature demonstrates that apoptotic mesenchymal cells and their derived vesicles can counteract type 2 diabetes, attenuate severe acute pancreatitis, improve wound healing, and influence ovarian dysfunction and hair growth. Continued research using CRISPR models and advanced methods will further clarify the mechanisms and therapeutic potential of this process.
References
- 1. Han J et al.. 2025. Mesenchymal stem cell-derived apoptotic vesicles: emerging cell-free strategy for periodontitis treatment.. J Nanobiotechnology 23(1):679 PMID: 41088289
- 2. Xu W et al.. 2025. Mesenchymal stem cell-derived apoptotic extracellular vesicles loaded with Prussian blue nanoparticles attenuate severe acute pancreatitis via neutrophil extracellular traps resolution and acinar-ductal metaplasia promotion.. J Nanobiotechnology 23(1):804 PMID: 41449408
- 3. Tang H et al.. 2022. Mesenchymal Stem Cell-Derived Apoptotic Bodies: Biological Functions and Therapeutic Potential.. Cells 11(23) PMID: 36497136
- 4. Bai XF et al.. 2024. [Placental mesenchymal stem cell exosome-derived miR-139-5p regulates PTEN gene and influences chemotherapeutic-induced ovarian dysfunction].. Zhonghua Fu Chan Ke Za Zhi 59(9):710-718 PMID: 39313423
- 5. Zheng C et al.. 2021. Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes.. J Extracell Vesicles 10(7):e12109 PMID: 34084287
- 6. Galleu A et al.. 2017. Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.. Sci Transl Med 9(416) PMID: 29141887
- 7. Wang Y et al.. 2023. Umbilical cord mesenchymal stem cell-derived apoptotic extracellular vesicles ameliorate cutaneous wound healing in type 2 diabetic mice via macrophage pyroptosis inhibition.. Stem Cell Res Ther 14(1):257 PMID: 37726853
- 8. Yan W et al.. 2024. Restoration of follicular β-catenin signaling by mesenchymal stem cells promotes hair growth in mice with androgenetic alopecia.. Stem Cell Res Ther 15(1):439 PMID: 39563459
